Stockwinners Market Radar for January 18, 2019 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service |
TCCO | Hot Stocks18:02 EDT Technical Comm Corp reports notice of failure to satisfy Nasdaq rule - Technical Communications Corporation announced that on January 16, 2019, the company received notice from the Nasdaq Listing Qualifications department of the Nasdaq Stock Market that, because TCC had not yet filed its Annual Report on Form 10-K for the fiscal year ended September 29, 2018, the company no longer complied with Nasdaq continued listing Rule 5250c1, which rule requires companies with securities listed on Nasdaq to timely file all required periodic reports with the U.S. Securities and Exchange Commission. Pursuant to such notice, the company will have 60 calendar days to submit a plan to Nasdaq to regain compliance; if the plan is accepted, Nasdaq can grant an exception of up to 180 days from the due date of the filing, or until July 15, 2019, to regain compliance.
|
TXT | Hot Stocks17:30 EDT Textron subsidiary awarded $439.56M government contract modification - Bell Helicopter Textron was awarded a $439.56M contract modification. This modification exercises an option for the production and delivery of 25 Lot 16 AH-1Z aircraft and 25 stores control units. Work is expected to be completed in January 2022.
|
TAC | Hot Stocks17:28 EDT Mangrove Partners reports 9.4% passive stake in TransAlta - In a regulatory filing, Mangrove Partners disclosed a 9.4% stake in TransAlta, representing nearly 27M shares. The filing does not allow for activism.
|
TDS | Hot Stocks17:27 EDT Telephone and Data's Meyers sells 80,465 common shares - In a regulatory filing, Telephone and Data director Kenneth R. Meyers disclosed the sale of 80,465 common shares of the company at a price of $29.90 per share.
|
FDX | Hot Stocks16:49 EDT FedEx establishes voluntary buyout program for U.S. workers - FedEx said in a regulatory filing that a voluntary buyout program for eligible U.S.-based employees is a component of FedEx Corporation's ongoing efforts to improve efficiencies and reduce costs. On January 18, 2019, FedEx and its wholly owned subsidiaries Federal Express Corporation and FedEx Corporate Services, Inc. began offering voluntary cash buyouts to eligible U.S.-based employees. The offer periods will expire in the fourth quarter of fiscal 2019. The U.S.-based employee voluntary buyout program includes voluntary severance payments to be calculated based on four weeks of gross base salary for every year of continuous FedEx service up to a maximum payment of two years of pay. It also includes funding to healthcare reimbursement accounts. These incentives do not include any changes to retirement eligibility or payments. However, employees who are eligible for this program and are also eligible to retire may elect to accept the voluntary buyout and retire. Costs of the benefits to be provided under the U.S.-based employee voluntary buyout program will be recognized in the period that eligible employees accept their offers, which is expected to be predominantly in the fourth quarter of fiscal 2019. The company expects the pre-tax cost of the U.S.-based program to range from $450M to $575M in pre-tax cash expenditures, but actual costs will depend on employee acceptance rates. FedEx expects savings from the U.S.-based program to be between $225M to $275M on an annualized basis beginning in fiscal 2020. Eligible employees will vacate positions in a manner to ensure a smooth transition in the impacted functions so that we maintain service levels to customers. The company expects for the majority of eligible and accepting employees to vacate their positions by the end of fiscal 2019.
|
MKL | Hot Stocks16:36 EDT Markel says Anthony Belisle, Alissa Fredricks no longer with company - Markel Corporation said that effective immediately, Anthony Belisle, Markel CATCo Chief Executive Officer and Alissa Fredricks, Markel CATCo Chief Executive Officer - Bermuda are no longer with the company. As previously announced, after being notified of governmental inquiries into loss reserves recorded in late 2017 and early 2018 at Markel CATCo Investment Management Ltd and its subsidiaries, Markel Corporation engaged outside counsel to conduct an internal review. During the course of the internal review, Markel discovered violations by Mr. Belisle and Ms. Fredricks of Markel policies relating to an undisclosed personal relationship, and prompt action was taken. The internal review relating to loss reserving continues with no conclusions reached at this time. Effective immediately, management and oversight of Markel CATCo, which includes approximately 25 employees, will be provided by Jed Rhoads, President and Chief Underwriting Officer, Markel Global Reinsurance, and Andrew "Barney" Barnard, Senior Managing Director, Head of International Property Catastrophe and Retro Reinsurance at Markel Global Reinsurance. Markel will commence a search for Markel CATCo's new Chief Executive Officer.
|
ABBV JNJ | Hot Stocks16:33 EDT AbbVie: Phase 3 study of ibrutinib did not meet primary endpoint - AbbVie (ABBV) announced an update on the Phase 3 RESOLVE trial of ibrutinib in combination with chemotherapy agents nab-paclitaxel and gemcitabine versus placebo in combination with these chemotherapy agents in patients with metastatic pancreatic adenocarcinoma (cancer). Metastatic pancreatic cancer is an aggressive and difficult-to-treat solid tumor primarily treated with chemotherapy today. IMBRUVICA is a first-in-class Bruton's tyrosine kinase inhibitor jointly developed and commercialized by Pharmacyclics LLC, an AbbVie company, and Janssen Biotech (JNJ). IMBRUVICA has been available in the U.S. since 2013 and is FDA-approved for use in five B-cell blood cancers, as well as in chronic graft-versus-host-disease for a total of nine FDA-approved indications. PCYC-1137 evaluated the efficacy of ibrutinib in combination with nab-paclitaxel and gemcitabine for the first-line treatment of patients with metastatic pancreatic cancer. Patients were randomized 1:1 to receive ibrutinib and nab-paclitaxel and gemcitabine combination treatment arm versus the placebo and nab-paclitaxel and gemcitabine combination treatment arm . At conclusion, the study did not meet its primary endpoint of improving progression-free survival or overall survival benefit among the study population. Safety data collected from the study were consistent with the existing safety information for the study therapies. The full results from this trial will be submitted for publication to a future scientific conference and/or a peer-reviewed medical journal.
|
PLD | Hot Stocks16:12 EDT Prologis, Ivanhoe Cambridge form $880M joint venture in Brazil - Prologis and Ivanhoe Cambridge announced the close of their agreement to form an approximately $880M, 20/80 joint venture in Brazil. Prologis Brazil Logistics Venture will develop and operate logistics real estate in Brazil, specifically in Sao Paulo and Rio de Janeiro. At closing, the venture acquired an initial portfolio of assets of approximately 6.9M square feet of operating properties and 371 acres of land from Prologis with a commitment to build out the existing land bank.
|
WHF | Hot Stocks16:09 EDT WhiteHorse Finance, STRS Ohio form JV to invest in debt facilities - WhiteHorse Finance, Inc. and State Teachers Retirement System of Ohio, a public pension fund established under Ohio law, announced that they have entered into an agreement to co-manage a newly-formed joint venture, WHF STRS Ohio Senior Loan Fund LLC, to invest primarily in lower middle market, senior secured debt facilities. The company and STRS Ohio have committed to provide up to $125M of subordinated notes and equity to the joint venture, with the company providing up to $75M and STRS Ohio providing up to $50M. In addition, the joint venture intends to seek up to $250M in third-party financing thereby providing WhiteHorse Finance up to $375M in lending capacity. Additional terms of the transaction were not disclosed.
|
CB | Hot Stocks16:07 EDT Chubb sees Q4 net catastrophe loss approximately $585M pre-tax, $505M after tax - Chubb announced net catastrophe loss estimates for the fourth quarter of 2018 of approximately $585M pre-tax, or $505M after tax. These estimates include the previously reported loss estimates related to the California wildfires and Hurricane Michael, which totaled $475M pre-tax, and $75M pre-tax related to other worldwide weather events in the fourth quarter, including storms in Australia and Typhoon Trami in Japan. The balance of approximately $35M pre-tax is from loss development related to natural catastrophes occurring in the first three quarters of the year. These estimates are net of reinsurance, include reinstatement premiums and comprise losses generated from the company's commercial and personal property and casualty insurance businesses as well as its reinsurance operations. The tax rate on catastrophe losses is impacted by the jurisdiction in which the losses are incurred. For the quarter, the tax rate on the catastrophe losses is 13.7%. As a result, the company now expects the core operating effective tax rate for the quarter to be 1.5 to 2.0 percentage points above the high end of the previously announced range.
|
ESEA | Hot Stocks16:07 EDT Euroseas receives Nasdaq notice of non-compliance - Euroseas Ltd. announced that it received notice from the Nasdaq Stock Market LLC dated January 14, 2019 indicating that the company is no longer in compliance with Nasdaq's continued listing requirements under Nasdaq Listing Rule 5550a2 because the closing bid price of the company's common stock over a period of 30 consecutive business days was less than $1.00 per share. Pursuant to Nasdaq Listing Rule 5810c3A, the company has six months following receipt of the notification to regain compliance with the minimum share price requirement. The company can cure this deficiency if the closing bid price of its common stock is $1.00 per share or higher for at least ten consecutive business days during the six months following the date of the Notice. Alternatively, the company could also take other actions to cure the deficiency, such as a reverse stock split. The company intends to cure the deficiency within the prescribed timeframe. During this time, the company's common stock will continue to be listed and trade on the Nasdaq Capital Market. The company's business operations are not affected by the receipt of the Notice.
|
MRK... | Hot Stocks16:04 EDT FDA approves Samsung Bioepis-Merck biosimilar to Roche's Herceptrin - The FDA announced that it approved Ontruzant, which is co-developed by Merck Sharp & Dohme (MRK) and Samsung Biopis, a joint venture between Samsung BioLogics (SSNLF) and Biogen (BIIB). Ontruzant is a biosimilar to Roche's (RHHBY) breast cancer treatment Herceptrin.
|
ESTA | Hot Stocks15:22 EDT RTW Investments reports 5.13% passive stake in Establishment Labs - In a regulatory filing, RTW Investments disclosed a 5.13% stake in Establishment Labs, which represents 1.05M shares. The filing does not allow for activism.
|
CODX | Hot Stocks14:36 EDT Bentley Rothschild reports 8.8% passive stake in Co-Diagnostics - In a regulatory filing, Bentley Rothschild Financial disclosed an 8.8% stake in Co-Diagnostics, which represents about 1.13M shares. The filing does not allow for activism.
|
MFSF | Hot Stocks14:29 EDT MutualFirst Financial to repurchase up to 430,000 shares - MutualFirst Financial, Inc. announced its intention to repurchase up to 430,000 shares or approximately 5% of its outstanding shares in the open market and in privately negotiated transactions. These shares will be purchased from time to time over a twelve-month period depending upon market conditions.
|
PYPL SYF | Hot Stocks14:04 EDT PayPal offers up to $500 credit for federal workers impacted by shutdown - PayPal (PYPL) said in a blog post that it is "stepping up" to help federal workers who are impacted by the government shutdown. Starting immediately, PayPal is offering an interest-free cash advance up to $500, the equivalent of one week's take home pay, for any existing or new PayPal Credit customers who are federal employees, and are struggling to make ends meet. "We have committed to fund up to $25M of interest-free cash advances to help federal government employees pay for food, gas, and other everyday necessities," the company said. "The program has been brought to life with the help of our partners at Synchrony (SYF) and we hope that it can provide some relief and certainty in uncertain times." Reference Link
|
TI | Hot Stocks14:00 EDT Telecom Italia establishes chief revenue office, entrusts to Lorenzo Forina - Telecom Italia announced the establishment of the Chief Revenue Office, entrusted to Lorenzo Forina, who will report directly to the CEO with responsibility for developing the company's commercial strategy for the entire Consumer/Small Enterprise and Business/Top Clients offering. Specifically, the new office will be responsible for ensuring, at group level, the operating margin of Retail clients, increasing client value, maximising income, profitability and market share by defining the offering, prices, marketing plans, go-to-market, ICT solution design, commercialisation of products/services and post-sales and care activities.
|
VZ T | Hot Stocks13:47 EDT NBA, Turner, Yahoo Sports announce launch of nightly studio show on mobile - The National Basketball Association, AT&T's (T) Turner Sports and Verizon's (VZ) Yahoo Sports announced they will debut a new live nightly studio show, "The Bounce," available exclusively on Yahoo Sports and the Yahoo Sports app on iOS and Android beginning Monday, Jan. 21. The show will then air five nights per week - Sunday, Monday, Wednesday, Friday and Saturday - from 8-11 p.m. ET through the end of the 2018-19 NBA regular season, Verizon stated in a press release regarding the show's launch. Reference Link
|
DIS | Hot Stocks13:07 EDT Disney says ESPN+ surpassed 1M subscribers in its first five months
|
DIS | Hot Stocks13:06 EDT Disney discusses upcoming slate of Disney+ content - The slate of Disney+ content currently in production includes the first-ever live-action Star Wars series, The Mandalorian; an original series based on Disney Channel's High School Musical; an animated series based on Pixar's Monsters, Inc. franchise; a new season of the Star Wars animated series, Clone Wars; a live-action version of the animated classic Lady and the Tramp; and a number of original docu-series. A live-action Marvel series starring Tom Hiddleston, a second Star Wars series starring Diego Luna, and other high-profile projects are also in development.
|
DIS | Hot Stocks13:05 EDT Disney recasts three years of results to reflect segment reorganization - Disney provided detailed financial information regarding its recently formed Direct-to-Consumer, or DTC, and International business segment in a filing, offering additional insight into the company's growing DTC business and its investment in technology and original content. The company recast financial results for the past three fiscal years to reflect the recent reorganization of Disney's business segments. This recast has no impact on prior-years' net income or earnings per share, and is intended to provide information useful to investors in analyzing the company's February 5 release of Q1 earnings, when financial results will be reported under the new segment structure. "Our top priority is fully leveraging our global brands and great content to create world-class direct-to-consumer entertainment," said Disney CEO Robert Iger. "We have the structure and management in place to drive growth in our DTC business, and our acquisition of 21st Century Fox further enhances our ability to deliver significant value to consumers and shareholders. Acquiring BAMTech enabled us to enter the DTC space quickly and effectively, as demonstrated by the success of ESPN+. The service surpassed 1M subscribers in its first five months and continues to grow as it expands its content mix, all of which bodes well for our upcoming launch of Disney+. The ability to connect directly with millions of Disney, Pixar, Marvel, and Star Wars fans creates tremendous opportunities for growth. In addition to leveraging our existing IP in new ways, we're making significant investments in original content exclusively for Disney+, creating an impressive pipeline of high-quality movies and series we believe will make the streaming service even more compelling for consumers."
|
MSB | Hot Stocks13:04 EDT Mesabi Trust trustees reaffirm support for successor trustee nominee Robin Radke - The Trustees of Mesabi Trust re-affirmed their unanimous support for successor trustee nominee Robin Radke to be appointed by unitholders at its adjourned Special Meeting of Trust Certificate Holders. The Trustees of Mesabi Trust are continuing to solicit proxies from its Trust Certificate Holders requesting that holders vote "FOR" approval of Proposal 1 for the appointment of Robin Radke as an individual trustee of Mesabi Trust to succeed Richard Lareau, who is retiring. The trustees said, "Key factors noted by the Trustees are Ms. Radke's understanding of the intricacies of Mesabi Trust from a legal, compliance, internal controls, corporate, governance and trust law perspective, which she gained from her eleven years of experience in working on a broad range of projects for the Trust. Based on a thorough diligence process reviewing biographical information and professional resumes of other potentially interested candidates, including conducting interviews of the top candidates, ensuring no conflict of interest exists and identifying the skills, experience and diversity profile the Trustees were seeking to address in a candidate, the Trustees unanimously concluded that Radke is the most qualified candidate to serve as Trustee of Mesabi Trust. The Trustees also selected Radke recognizing that evolving regulatory and corporate governance standards are beginning to establish guidelines for the promotion of women on corporate boards and agree that a diverse and inclusive board promotes a broader range of viewpoints and independent thinking." As previously disclosed, the Trustees also emphasize that two independent proxy advisory firms, Institutional Shareholder Services and Glass, Lewis & Co. have also recommended that Mesabi Trust unitholders vote "FOR" Proposal 1 for the appointment of Robin Radke.
|
BHGE | Hot Stocks13:04 EDT Baker Hughes reports U.S. rig count down 25 to 1,050 rigs - Baker Hughes reports that the U.S. rig count is down 25 rigs from last week to 1,050 rigs, with oil rigs down 21 to 852 and gas rigs down 4 to 198. The U.S. Rig Count is up 114 rigs from last year's count of 936, with oil rigs up 105 and gas rigs up 9. The U.S. Offshore Rig Count is down 2 rigs to 19 and unchanged at 19 year-over-year. The Canada Rig Count is up 25 rigs from last week to 209, with oil rigs up 25 to 128 and gas rigs unchanged at 81. The Canada Rig Count is down 116 rigs from last year's count of 325, with oil rigs down 80 and gas rigs down 36.
|
HUSA | Hot Stocks13:01 EDT Houston American Energy announces completion of San Andres prospect drilling - Houston American Energy provided an update with respect to drilling operations on its San Andres prospect in Yoakum County, Texas. The Frost #1H well, the company's first well on the prospect, has reached total depth of approximately 10,000 feet, including an approximately 4,800-foot horizontal leg, and casing is being set. The operator has advised that it plans to initiate fracking of the well in the immediate future. The well, located in the Northwest Shelf of the Midland Basis, targeted the "Exploration" component of the San Andres Formation. Houston American Energy holds a 12.5% working interest in the 650-acre prospect.
|
TELL | Hot Stocks12:49 EDT Tellurian Driftwood LNG receives FEIS from FERC - Tellurian announced that the U.S. Federal Energy Regulatory Commission, or FERC, issued the final Environmental Impact Statement, or FEIS, for Driftwood LNG, an approximately 27.6M tonne per annum liquefied natural gas export facility and an associated 96-mile pipeline, proposed near Lake Charles, Louisiana, on the U.S. Gulf Coast. Tellurian CEO Meg Gentle said, "Tellurian thanks the FERC for a thorough review and for remaining on schedule. We look forward to receiving the agency's order granting authorization to site, construct and operate our Driftwood project. Tellurian will then stand ready to make a final investment decision and begin construction in the first half of 2019, with the first LNG expected in 2023."
|
LUB | Hot Stocks12:40 EDT Luby's stockholder says board's promises 'too little too late' - Bandera Partners, a stockholder of Luby's (LUB), issued the following letter to Luby's stockholders. "Just over 10 years ago, when Luby's was engaged in a tight proxy contest with an activist investor, the incumbent board instituted some long overdue governance changes to swing votes back in their favor. Luby's incumbent board narrowly won that contest, and the stock has since fallen over 80% under its watch. Don't let them fool you twice with their latest round of promises. Today, in response to a wave of support for Bandera's irrefutable case that the board has grossly underperformed since that last proxy contest, Luby's is proposing a new round of changes and sweetened promises, including swapping in new directors, hand-picked by the underperforming incumbent board, AFTER the election, with an uncertain timeline. We do not believe Luby's stockholders are going to fall for these campaign tactics for a second time. If stockholders want real and immediate change to the Luby's board, they should vote only the GOLD proxy. If the newly elected board wishes to discuss additional board refreshment this coming year, we will welcome that discussion. Today's announcement from Luby's is simply too little too late. The incumbent board has consistently disregarded Luby's outside stockholders for the past decade. They are running an aggressive and expensive campaign that ISS has already called "deceptive." Why should anyone trust them to select new directors that will hold management accountable for its performance? Only a vote on the GOLD proxy card will elect directors who owe nothing to the incumbent board that has overseen this extended period of catastrophic value destruction."
|
EXP | Hot Stocks12:18 EDT Adage Capital Partners reports 4.81% passive stake in Eagle Materials - In a regulatory filing, Adage Capital Partners disclosed a 4.81% stake in Eagle Materials, which represents 2.25M shares. The filing does not allow for activism.
|
IVC | Hot Stocks12:00 EDT Invacare falls -7.0% - Invacare is down -7.0%, or -37c to $4.89.
|
DWT | Hot Stocks12:00 EDT Britannia Bulk falls -7.6% - Britannia Bulk is down -7.6%, or -79c to $9.57.
|
NLS | Hot Stocks12:00 EDT Nautilus falls -39.0% - Nautilus is down -39.0%, or -$4.60 to $7.19.
|
HCLP | Hot Stocks12:00 EDT Hi-Crush Partners rises 9.7% - Hi-Crush Partners is up 9.7%, or 42c to $4.74.
|
VFC | Hot Stocks12:00 EDT VF Corp. rises 11.4% - VF Corp. is up 11.4%, or $8.36 to $81.62.
|
PCG | Hot Stocks12:00 EDT PG&E rises 12.7% - PG&E is up 12.7%, or 81c to $7.17.
|
PHUN | Hot Stocks11:49 EDT Phunware Inc trading resumes
|
IZEA | Hot Stocks11:48 EDT Izea continues to expand relationship with Fortune 10 customer - IZEA Worldwide announced that it continues to expand its direct relationship with a Fortune 10 customer. The customer began working directly with IZEA in 2017 after a successful pilot program with an agency partner. Direct spend grew 380% from 2017 to 2018, and in 2018 the customer's aggregated commitment reached the high-seven figure mark. In the first few weeks of 2019, IZEA has received additional commitments from this customer, and Q1 2019 spend is already above the total spend in Q1 2018.
|
RTN | Hot Stocks11:47 EDT Raytheon awarded $17M contract modification - Raytheon Missile Systems was awarded a $17M contract modification to exercise an option for providing Zumwalt capability and design agent support to the Standard Missile-2. FY17 and FY18 weapons procurement, and foreign military sales funding in the amount of $16.95M will be obligated at time of award and will not expire at the end of the current fiscal year.
|
PHUN | Hot Stocks11:39 EDT Phunware Inc trading halted, volatility trading pause
|
PETX | Hot Stocks11:10 EDT Aratana turns higher after activist said to bet on takeover - Shares of Aratana Therapeutics have recovered off earlier session lows and moved into positive territory after The Deal reported, citing people familiar with the situation, that activist investor Engaged Capital is increasing its stake in the company because Engaged's Glenn Welling believes there is a good chance the company could sell itself. Welling, who has "quietly hiked" Engaged's stake in Aratana to 4.9%, thinks the pet drug company will seek to sell itself shortly, The Deal stated, according to contacts. The Fly notes that in October Dealreporter said that the company was working with Barclays as a financial advisor to explore its strategic alternatives. According to the report from the deal-focused news service, Aratana previously committed to activist investor Engaged Capital that it would appoint a board committee to conduct a strategic review by no later than July 1 and the company has been following the cooperation agreement's timeline. In morning trading, Aratana shares are up 10c, or 2.4%, to $4.24.
|
KEYS | Hot Stocks11:03 EDT Keysight, CharIN collaborate for CCS for battery-powered vehicles - Keysight Technologies is now a member of the CharIN association which speeds the advancement of the Combined Charging System for battery powered vehicles. In support of CharIN's efforts to establish a global standard for electric vehicle charging, Keysight will offer expertise in charging communication protocols, power electronics, electromagnetic compatibility, and measurement technology. To drive e-mobility innovations and concepts on a global basis, Keysight will actively support the implementation of direct current fast chargers, as well as join forces with CharIN to help guarantee interoperability between electric vehicles and charging stations.
|
WIT | Hot Stocks10:50 EDT Wipro sees Q4 IT Services revenue $2.047B-$2.088B
|
STT | Hot Stocks10:28 EDT State Street targeting 4% productivity savings in FY19 - State Street is targeting 4% productivity savings which would result in approximately 1% underlying expense reduction. The firm sees slowing global growth, market forward interest rates, modest 5% growth in equity markets, and light flows as well as muted client activity in the market and operating environment during 2019. In capital return, the firm is targeting total payout greater than 80%. The firm is reinstating its share repurchases and sees repurchasing up to $600M in stock by June 30. Management is reinitiating capita returns and aggressively managing expenses in FY19. Management noted the firm is better positioned for the FY19 CCAR cycle. Comments and guidance provided during Q4 earnings conference call and presentation slides.
|
STT | Hot Stocks10:08 EDT State Street implemented firm-wide hiring freeze - Comments provided during Q4 earnings conference call.
|
KURA | Hot Stocks10:02 EDT Kura reports new findings from previously conducted tipifarnib Phase 3 trial - Kura Oncology reported new findings identifying a potential association between CXCL12 expression and clinical benefit in patients with pancreatic cancer treated with tipifarnib. These findings are being presented today at the 2019 Gastrointestinal Cancers Symposium, the company announced. "We are very encouraged by these results, which we believe support the development of tipifarnib in pancreatic cancer. In December 2018, we presented prospective proof-of-concept data in peripheral T-cell lymphoma which we believe validated our initial observations on tipifarnib as a CXCL12 pathway inhibitor in lymphoma and acute myeloid leukemia. This study now extends the therapeutic potential of tipifarnib to pancreatic cancer, and we intend to explore opportunities for further development of tipifarnib in this and other CXCL12-expressing hematologic and solid tumor indications," said Antonio Gualberto, Head of Development and Chief Medical Officer of Kura Oncology.
|
VOC | Hot Stocks10:00 EDT VOC Energy Trust falls -6.0% - VOC Energy Trust is down -6.0%, or -28c to $4.39.
|
UGAZ | Hot Stocks10:00 EDT VelocityShares 3x Long Natural Gas ETN falls -8.1% - VelocityShares 3x Long Natural Gas ETN is down -8.1%, or -$4.44 to $50.50.
|
NLS | Hot Stocks10:00 EDT Nautilus falls -41.5% - Nautilus is down -41.5%, or -$4.89 to $6.89.
|
ZAYO | Hot Stocks10:00 EDT Zayo Group rises 7.0% - Zayo Group is up 7.0%, or $1.79 to $27.42.
|
DGAZ | Hot Stocks10:00 EDT VelocityShares 3x Inv Natural Gas ETN rises 8.2% - VelocityShares 3x Inv Natural Gas ETN is up 8.2%, or $5.82 to $76.91.
|
VFC | Hot Stocks10:00 EDT VF Corp. rises 12.7% - VF Corp. is up 12.7%, or $9.31 to $82.57.
|
LUB | Hot Stocks09:52 EDT Luby's to accelerate plans for board transformation, governance changes - Luby's announced changes to its board as well as its corporate governance policies. As part of its commitment to ongoing board refreshment, in 2019 the company will add two new independent directors to replace two incumbent directors, and the board will choose a new chair. "Luby's has recently been engaged in in-depth discussions with many of our shareholders, and based on the feedback we have received, we have chosen to accelerate our plans to transform the Board and to move forward with several corporate governance changes," said Gasper Mir, III, Independent Chairman of Luby's. "With the planned addition of these two new directors and the already-announced addition of Twila Day to our slate of nominees for the 2019 Annual Meeting of Shareholders, we will have three new independent directors added to the Board this year - ensuring that we continue to have the right mix of experience and skillsets, coupled with fresh perspectives, to help steer the turnaround that is underway at Luby's and create value for all shareholders. As I am approaching the Board's retirement age limit, I have also decided to hand over the chairmanship to another independent director this year. The Board will choose a new chair in 2019." The Luby's Board will also elect a new independent Chairman of the Board in 2019. Gasper Mir, III, will remain on the Board as an independent director. Luby's will introduce a plurality voting standard for contested director elections moving forward. For legal reasons, it is not possible to change the vote standard for the upcoming 2019 Annual Meeting.
|
ZEAL | Hot Stocks09:50 EDT Zealand Pharma AS (ADS) trading resumes
|
FTEO | Hot Stocks09:50 EDT FRONTEO Inc (ADS) trading resumes
|
CVRR | Hot Stocks09:47 EDT CVR Refining falls -4.7% - CVR Refining is down -4.7%, or -52c to $10.51.
|
UGAZ | Hot Stocks09:47 EDT VelocityShares 3x Long Natural Gas ETN falls -8.6% - VelocityShares 3x Long Natural Gas ETN is down -8.6%, or -$4.75 to $50.19.
|
NLS | Hot Stocks09:47 EDT Nautilus falls -37.8% - Nautilus is down -37.8%, or -$4.46 to $7.33.
|
STT | Hot Stocks09:47 EDT State Street rises 6.1% - State Street is up 6.1%, or $4.32 to $75.37.
|
DGAZ | Hot Stocks09:47 EDT VelocityShares 3x Inv Natural Gas ETN rises 8.4% - VelocityShares 3x Inv Natural Gas ETN is up 8.4%, or $6.00 to $77.09.
|
VFC | Hot Stocks09:47 EDT VF Corp. rises 11.6% - VF Corp. is up 11.6%, or $8.50 to $81.76.
|
ZEAL | Hot Stocks09:45 EDT Zealand Pharma AS (ADS) trading halted, volatility trading pause
|
FTEO | Hot Stocks09:45 EDT FRONTEO Inc (ADS) trading halted, volatility trading pause
|
WIN | Hot Stocks09:34 EDT Windstream Wholesale to expand long-haul core network into Canada - Windstream Wholesale announced that it will use existing long-haul fiber assets to expand its core network by over 200 miles into Montreal, Quebec. The expansion will connect Windstream's network within Cologix's Montreal ecosystem, including its MTL3 data center at 1250 Rene-Levesque. Cologix is the leading data center operator in the Montreal market with nine data centers and over 400,000 square feet of space with connections to all the major cloud service providers in the industry. "This Network expansion supports our continued mission to connect people and empower business to a world that enables infinite possibilities," said Buddy Bayer, chief network officer at Windstream. "With the demand level for services we're experiencing, it just made logical sense to utilize our fiber assets and expand the core network into Cologix's Montreal ecosystem allowing any of their customers to cross-connect to Windstream for service."
|
HX | Hot Stocks09:33 EDT Hexindai says short seller allegations 'baseless' - Hexindai announced its rebuttal to the "unsubstantiated allegations of a short seller this week," stating that the company believes that the "allegations made contain numerous errors and unsupported speculation." The company, which said it stands by its financial reporting, intends to take "all appropriate legal actions to defend itself against the malicious allegations and to protect the interest of its shareholders."
|
YORW | Hot Stocks09:32 EDT York Water announces settlement of rate case - Jeffrey Hines, President and CEO of The York Water Company, announced that the Pennsylvania Public Utility Commission approved a settlement at its January 17 meeting, allowing an increase in base rates for water and wastewater customers of The York Water Company. The settled rates provide for cost recovery for York Water, while maintaining affordability to customers. It is estimated that the settlement will increase the average residential water bill for customers using 4,001 gallons from $42.81 per month to $43.93 per month, or just over $1 per month.
|
TOL JPM | Hot Stocks09:32 EDT Toll Brothers JPMorgan Asset management JV to develop 421 unit rental community - Toll Brothers (TOL), through its Toll Brothers Apartment Living rental subsidiary, and institutional investors advised by J.P. Morgan Asset Management (JPM), have announced the formation of a new joint venture to develop Carraway, a 421-unit luxury apartment community in Harrison, New York. The joint venture partnership has secured a $102M construction loan facility evenly split among Wells Fargo, National Association, serving as administrative agent, and Capital One. The total project cost is approximately $157M. The debt and equity financing were arranged by Toll Brothers' in-house Finance Department. Toll Brothers Apartment Living will manage the development, marketing, leasing and property management of Carraway.
|
USX | Hot Stocks09:26 EDT U.S. Xpress Enterprises to record non-cash, pre-tax charge of $12.3M in Q4 - The Company expects to record a non-cash, pre-tax charge of approximately $12.3M in the fourth quarter of 2018 to reflect the write down of the total investment in Xpress Internacional, which U.S. Xpress had operated since 2007. In addition, the Company expects to incur one-time expenses during the first quarter of 2019 related to the transition plan to shut down its domestic infrastructure that supported the cross border business, this expense is not expected to exceed $4M. on a pre-tax basis. The plan is estimated to have the following annualized financial impact following full implementation and collection of all installments of deferred proceeds: ($39.2M) on consolidated revenue, $10M on consolidated operating income, $20M on consolidated cash proceeds. The Company expects to repay debt with the cash proceeds generated from the exit. In the fourth quarter, the Company's residual investment of 10% of the common equity of Xpress Global Systems was extinguished. The investment was carried at a value of approximately $1M and will be recorded as a loss on investment with an after-tax impact of approximately 2c per diluted share.
|
SLB | Hot Stocks09:25 EDT Schlumberger says Canada, Argentina asset sales a priority
|
USX | Hot Stocks09:22 EDT U.S. Xpress Enterprises announces disposition of investment in U.S.-Mexico ops - U.S. Xpress Enterprises announced its plan to exit its U.S. - Mexico cross border investment as part of its ongoing capital allocation and profit improvement initiatives. When fully implemented, the plan is expected to reduce current and planned invested capital by approximately $40M, improve the Company's consolidated operating margin, and offer customers continued access to cross border service through a variable cost alternative. In connection with this plan, as well as the disposition of its remaining 10% equity investment in a former subsidiary, the Company expects to record an approximate $12.3M non-cash, pre-tax loss on equity investments for the fourth quarter of 2018. These changes mark the latest step in the Company's continued execution of its strategic overhaul designed to drive operational improvement as U.S. Xpress strives to deliver its third consecutive year of margin improvement in 2019. The plan will be executed in stages over the next several months. The Company's cross border business consists of 95% equity ownership in Xpress Internacional. In addition, to serve the business the Company maintains fixed investments in the United States consisting of a trucking terminal in Laredo, Texas, approximately 700 incremental dry van trailers, and tractor capacity allocated toward serving freight to and from the border. Including the allocated cost of the U.S. investments and personnel, the cross border business generated approximately $50M in revenue but insignificant operating income in 2018. As part of U.S. Xpress's ongoing transformation, the Company made the decision to exit its fixed cost investment in the cross border business and sold its investment in the Mexican entity to the existing managers. The operational transition is expected to be complete during the second quarter of 2019. The exit involves the following components, which will be executed over the next several months: Sale of the Company's 95% equity ownership of Xpress Internacional for an estimated $4.5M in cash and an additional $8.5M in cash to be received over 8.5 years. The equity sale has been completed. Closing and sale of the Company's trucking terminal in Laredo, Texas, and disposition of approximately 700 dry van trailers allocated toward the Mexico business as these trailers complete the transition phase. The terminal is valued at an estimated $7M, and the trailers had been slated for replacement over the next two years at an estimated cost of $20M. This operational transition is anticipated to be completed during 2019. Repositioning approximately 300 domestic tractors from loads to and from the border to more profitable loads through network optimization over a transition period, while continuing to offer customers ongoing access to cross-border service on a variable cost basis through relationships with our former partners, anticipated to be completed in 1H19.
|
IMMU | Hot Stocks09:19 EDT Immunomedics down 36% after receiving CRL for breast cancer treatment - Following a resumption of pre-market trading, Immunomedics shares are down $6.44, or 35.6%, to $11.65. Last night, Immunomedics announced it has received a Complete Response Letter from the FDA for the Biologics License Application, or BLA, seeking accelerated approval of sacituzumab govitecan for the treatment of patients with metastatic triple-negative breast cancer who have received at least two prior therapies for metastatic disease.
|
SLB | Hot Stocks09:11 EDT Schlumberger says expects to be in 'low end of range' of Q1 seasonal slowdown - Says likely to produce more cash in FY19 vs. FY18.
|
AMZN | Hot Stocks09:03 EDT Amazon: Over 50,000 small, medium-sized businesses exceeded $500,000 in sales - Amazon announced that more than 50,000 small and medium-sized businesses exceeded $500,000 in sales in Amazon's stores worldwide, and nearly 200,000 surpassed $100,000 in sales in our stores. The number of small and medium-sized businesses eclipsing $1M in sales in Amazon's stores worldwide grew by 20% in 2018. Millions of small and medium-sized businesses from around the world are selling in Amazon's stores and more than a million of them are based in the U.S. Small and medium-sized businesses selling in Amazon's stores come from every state in the U.S., and from more than 130 different countries around the world. Third-party sales are growing at a faster rate than first-party sales on Amazon and across retailers in the U.S. During the 2018 holiday season, Amazon reported that sales by small and medium-sized businesses outpaced its retail business sales in Amazon's stores worldwide. 2018 Amazon Stores Highlights: Nearly 200,000 small and medium-sized businesses sold more than $100,000 in Amazon's stores in 2018. More than 50,000 small and medium-sized businesses exceeded $500,000 in sales in our stores in 2018. The number of small and medium-sized businesses eclipsing $1M in sales in Amazon's stores worldwide grew by 20% in 2018. Small and medium-sized businesses in the U.S. using Fulfillment by Amazon more than doubled their export sales. More than half of units sold in Amazon's stores are from small and medium-sized businesses. Small and medium-sized businesses selling in Amazon's stores exceeded $1.5B in sales during the Prime Day event. Amazon Storefronts launched, featuring more than 1M products from 20,000 U.S. small and medium-sized businesses. In 2018, Amazon introduced the Small Business Impact Report. According to the report, small and medium-sized businesses selling in Amazon's stores are estimated to have created more than 900,000 jobs worldwide.
|
AJG | Hot Stocks09:01 EDT Arthur J. Gallagher acquires Interstate Insurance Underwriters - Arthur J. Gallagher acquired Shreveport, Louisiana-based Interstate Insurance Underwriters. Terms of the transaction were not disclosed. Founded in 1963, Interstate Insurance Underwriters is a managing general agency offering a variety of property/casualty coverages through agents and brokers throughout the state of Louisiana, with a focus on general liability, property, garage and inland marine risks.
|
NFLX... | Hot Stocks08:59 EDT Fly Intel: Pre-market Movers - HIGHER: CVS Health (CVS), up 2.5% after the company and Walmart (WMT) announced that they have reached a multi-year agreement on terms under which Walmart will continue participating in the CVS Caremark pharmacy benefit management commercial and managed Medicaid retail pharmacy networks... Sportsman's Warehouse (SPWH), up 6% after Piper Jaffray analyst Peter Keith upgraded the stock to Overweight and raised his price target for the shares to $8 from $6. The company is "poised for substantially better fundamentals" while the shares trade at the "lowest valuation within our coverage universe," Keith tells investors. UP AFTER EARNINGS: VF Corp. (VFC), up 9%... Atlassian (TEAM), up 8%... Bank OZK (OZK), up 14%. DOWN AFTER EARNINGS: Netflix (NFLX), down 1%. ALSO LOWER: Tesla (TSLA), down 6.5% after announcing a 7% workforce reduction... Interpublic Group (IPG), down 4.5% after RBC Capital analyst Steven Cahall downgraded shares to Sector Perform and lowered his price target to $24 from $28. The analyst expects the company's organic growth to decelerate in 2019 after "recent account losses"... Casa Systems (CASA), down 28% after cutting its Q4 guidance and narrowing its FY18 guidance.
|
SLB | Hot Stocks08:56 EDT Schlumberger says sees FY19 fleet equipment CapEx $1.5B-$1.7B - Says doesn't see any "significant consumption" of cash for M&A in 2019. Comments from company's Q4 earnings conference call.
|
VFC | Hot Stocks08:53 EDT VF Corp. 'confident' North Face can sustain HSD growth heading into 2020 - Says confident North Face can sustain HSD growth as company heads into 2020. Says international business was softer than expected for Timberland. Expects LSD growth for the brand in 2020. Says majority of $45M incremental investments expected in Q4. Says has optionality to both pursue M&A agenda and return cash to shareholders.
|
AIPT | Hot Stocks08:50 EDT Precision Therapeutics CEO Carl Schwartz invests $1M in the company - Precision Therapeutics announced that its CEO and director, Carl Schwartz, has made an additional investment of $1M in the company, effective January 8. Of this investment, $950,000 was a loan under an amended and restated promissory note, which now covers advances of $1.32M including a previous loan Schwartz made in November 2018. He also purchased 78,125 shares of the company's common stock in a private investment for $50,000, representing a price of 64c er share. As part of the investment, which is detailed in a Form 8-K filed with the United States Securities and Exchange Commission, Schwartz also received additional warrants to purchase company common stock. In addition, Schwartz, since assuming the role of CEO, has elected to take his salary in the form of stock options, rather than cash, which further increases his equity stake in the company.
|
VFC | Hot Stocks08:42 EDT VF Corp. says impact from geopolitical uncertainty has been 'minimal' - Says Vans delivered "exceptional" quarter of growth. Says international business remains 'resilient' amid political uncertainty. Says investments and focus in D-to-C continue to pay off. Says confident in growth trajectory heading into 2019. Says impact to business from geopolitical uncertainty has been 'minimal', but company is continuing to monitor situation closely and developing contingency plans. Says big three brands grew at a rate of 14%. Says momentum in the North Face continues to build. Says confident in growth trajectory in North Face heading into 2019. Says well-positioned for end of April 2019 separation of Kontoor Brands. Says confident in foundation for sustainable, long-term growth. Says continues to invest in strategic priorities. Says confident growth trajectory is sustainable as company heads into 2020. Says government shutdown has potential to delay public filing for spinoff of Kontoor Brands. Comments taken from Q3 earnings conference call.
|
TYME | Hot Stocks08:31 EDT Tyme Technologies trading resumes
|
HII | Hot Stocks08:28 EDT Huntington Ingalls to acquire Fulcrum IT Services - Huntington Ingalls announced that it has entered into an agreement to acquire Fulcrum IT Services, an information technology and government consulting company headquartered in Centreville, Virginia. The planned acquisition is expected to close in February. Financial terms of the transaction were not disclosed. Fulcrum expands HII's capabilities in enhanced situational awareness and predictive threat analytics through Fulcrum's advanced engineering, cyber security, software development, big data engineering, and intelligence and special operations experience. Fulcrum will join HII's technical solutions division.
|
EDAP | Hot Stocks08:23 EDT EDAP TMS announces Focal One sale to Brooklyn medical center - EDAP TMS announced that Brooklyn, New York's Maimonides Medical Center has become the second hospital in the United States, and the first on the East Coast, to acquire the Focal One high intensity focused ultrasound, or HIFU, technology. Maimonides Medical Center urologists were recently trained on the use of Focal One and will begin to schedule the outpatient treatments for eligible patients with localized prostate cancer in February.
|
TYME | Hot Stocks08:21 EDT Tyme Technologies announces SM-88 data shows improved survival benefit - Tyme Technologies announced that an open label phase II clinical trial evaluating SM-88 as a monotherapy in end-stage patients with advanced pancreatic cancer demonstrated substantially improved survival benefit compared to expected median overall survival outcomes.The 88-Panc open label phase II trial investigation involved 38 heavily pretreated patients with actively progressing metastatic pancreatic cancer who had received a median of two prior systemic therapies, and had significant disease related mortality. Researchers found that 68% of patients treated with SM-88, remained alive after a median of 4.3 months of follow-up. Median survival has not been concluded for either evaluable or intent-to-treat, or ITT, subjects with 60% of ITT subjects still alive. The survival data with SM-88 is significantly longer than published results in historical trials for comparable patients. SM-88 was well tolerated with only 2 serious adverse events, or SAEs, deemed at least potentially-related to SM-88. These SAEs both occurred in one patient, who continued on SM-88 treatment. The 88-Panc results are from an investigational study. SM-88 is not approved for the treatment of patients with advanced pancreatic cancer.
|
WTER | Hot Stocks08:14 EDT Alkaline Water enters agreement with WSO to expand production, distribution - Alkaline Water announced it has entered into a management and services agreement with Austin, Texas-based Water Source One, or WSO, to expand its production and distribution capabilities. Under the agreement, Water Source One will assist the company in managing the production and distribution of its flagship Alkaline88 premium bottled alkaline drinking water across the United States, including providing customer service and regulatory support, quality assurance management, and raw materials and logistical support. As WSO is one of the country's producers and suppliers of bottled water products, the company is confident that this partnership will allow it to aggressively scale the Alkaline88 brand. Water Source One supplies from more than 30 strategically placed bottling facilities located across the U.S. that all meet or exceed FDA regulations and are safe quality food certified. These facilities are expected to enable the company to lower shipping costs and solidify its growing national manufacturing footprint. Water Source One has the manufacturing capability to support the growing demand the company is seeing for its products and to enable it to scale production and distribution as the Alkaline88 brand continues to expand. The company expects to benefit from Water Source One's experienced management team. Many WSO team members are long-term veterans from major beverage companies.
|
STT | Hot Stocks08:11 EDT State Street to reduce workforce by 6%, or approximately 1,500 employees - State Street has initiated a new expense program to accelerate efforts to become a higher-performing organization and help navigate challenging market and industry conditions. Through increased resource discipline, process re-engineering and automation, State Street expects to realize $350 million in underlying expense savings in 2019. As part of the expense program's initiation, 4Q18 expenses included a repositioning charge of $223 million, including $198 million of compensation and employee benefits and $25 million of occupancy costs. The expense program includes: Reduction of senior managers by 15% through management delayering and aligning global organizations ; Introduction of a more rigorous performance management system; Increased vendor management in subcustody and professional services; Optimization of real estate footprint; Workforce reduction of 6%, or approximately 1,500 employees, in high cost locations as the Company realizes benefits of automation and standardized global processes; Rationalization and streamlining of 3 operational hubs and 2 joint ventures; Retirement of legacy applications and accelerated move to common platforms; Limiting regional and client operating differences and reducing the number of manual, bespoke activities.
|
BPTH | Hot Stocks08:10 EDT Bio-Path Holdings announces 1-for-20 reverse stock split - Bio-Path Holdings announced a 1-for-20 reverse stock split of its issued and outstanding common stock, which was previously approved by the company's board and stockholders. The reverse stock split became effective on January 17 and the company's shares of common stock will begin trading on a split-adjusted basis on the Nasdaq Capital Market at the commencement of trading under the company's existing symbol. The company's common stock has been assigned a new CUSIP number of 09057N300 in connection with the reverse stock split. As a result of the reverse stock split, every 20 shares of common stock issued and outstanding were consolidated into one issued and outstanding share. The reverse stock split reduced the company's issued and outstanding shares of common stock from approximately 22.2M to approximately 1.1M. In addition, proportionate adjustments will be made to the exercise prices of the company's outstanding stock options and warrants and to the number of shares issued and issuable under the company's existing stock incentive plans.
|
AIMT LLY | Hot Stocks08:08 EDT Aimmune appoints Andrew Oxtoby as Chief Commercial Officer - Aimmune Therapeutics (AIMT) announced the appointment of Andrew Oxtoby as Chief Commercial Officer. Oxtoby, a proven pharmaceutical executive with two decades of experience in the healthcare and consumer products industries, will join Aimmune in the newly created role on Tuesday, January 22. Oxtoby joins Aimmune from Eli Lilly (LLY), where he most recently had responsibility for Lilly's U.S. insulin business as Vice President of U.S. Diabetes Connected Care and Insulins
|
FTEK | Hot Stocks08:08 EDT Fuel Tech to suspend pollution control operation in China subsidiary - Fuel Tech announced the planned suspension of its Air Pollution Control business operation in China. This action is part of Fuel Tech's ongoing operational improvement initiatives designed to prioritize resource allocation, reduce costs, and drive profitability for the Company on a global basis. The transition associated with the suspension of the APC business is underway, and includes staff rationalization, supplier and partner engagement, and the monetization of certain assets. The Company expects to complete the process by the end of the second quarter of 2019. For the full year ended December 31, 2017 and nine months ended September 30, 2018, revenues at Beijing Fuel Tech were $8M and $2.4M, respectively, and operating losses totaled $1.7 million and $1.6 million, respectively. The Company expects to record charges associated with the suspension of the APC operation at Beijing Fuel Tech in 2019, however, these amounts have not yet been established. CEO Vincent Arnone said, "The operational improvement initiatives undertaken by Fuel Tech over the last few years have significantly lowered the Company's expense profile, narrowed operating losses, and allowed the Company to maintain a strong cash position. Fuel Tech returned to operating profitability in Q3 2018, driven by a 19% increase in total revenue and a 17% decline in SG&A compared to the prior year period. We reiterate our forecast for continuing operational improvement in 2018 when compared to 2017. This includes higher total revenues, profitability from continuing operations, and positive cash flow generation."
|
HSC | Hot Stocks08:08 EDT Harsco enters into 10-year contract with JSW Steel - Harsco announced that its metals & minerals division has entered into a multiyear contract with JSW Steel, steel exporter, to provide a range of mill services. The 10-year agreement commences in September. Under the multiyear contract, Harsco will provide JSW Dolvi with on-site slag handling services including under-furnace digging, ladle wrecking and hot slag transport. These services are directly linked to active steel production and critical for plant operations.
|
KBH... | Hot Stocks08:07 EDT KB Smart Home System with Google Assistant to come standard in SoCal communities - KB Home (KBH) announced that the KB Smart Home System will be offered as a standard feature at two of its Orange County communities: Highmark at Ironridge in Lake Forest and Prado at Cadence Park in Irvine. The KB Smart Home System, which leverages the power of Google Assistant (GOOG, GOOGL) to integrate a curated selection of voice- and smartphone-controlled features, will also be available as an option for all buyers who purchase a new KB home at any of the builder's other communities in Orange and San Diego counties. "We are pleased to be the first homebuilder in Southern California to enter a partnership with Google," said Steve Ruffner, regional president for KB Home. The KB Smart Home system features top-of-the-line products and is designed to accommodate additional emerging technologies as they come to market. The components include: Google Wifi "mesh" network that is designed to deliver consistently strong and secure signal throughout the home; Two smart speakers, including a Google Home, and a Google Home Mini, with voice control and automation by Google Assistant; Nest Hello Video Doorbell; Professional installation and integration of all devices for seamless interconnectivity.
|
KSU | Hot Stocks08:06 EDT Kansas City Southern enters 2019 with renewed focus on 'operational excellence' - "While we delivered record revenues, adjusted operating income and adjusted earnings per share, 2018 did not meet our own expectations for financial or operational performance," stated CEO Patrick Ottensmeyer. "In addition, we did not meet the expectations of our customers or shareowners, particularly in the areas of customer service and growth. KCS has entered 2019 with a renewed and heightened focus on operational excellence. Throughout the year, we will implement principles of the Precision Scheduled Railroading methodology that are most applicable to our network. We expect this focus on operational excellence and PSR principles to help drive improvement in asset utilization, cost and capital efficiency and customer satisfaction. As we look forward, our confidence in topline growth and operational improvement is strong, supporting our outlook for an operating ratio of 60% to 61% by the year 2021."
|
GME | Hot Stocks08:03 EDT GameStop announces global holiday sales of $2.63B - GameStop reported sales results for the nine-week holiday period ended January 5. Total global sales for the holiday period were $2.63B, a 5% decrease compared to the 2017 nine-week holiday period ended December 30, 2017. Total comparable store sales increased 1.5%, including a 3.6% increase in the U.S. partially offset by a 3.1% decrease internationally. Comparable store sales are calculated comparing the nine weeks ended January 5 to the nine weeks ended January 6, 2018 in order to ensure the appropriate weeks around the holiday are compared. The primary contributor to the difference between the increase in comparable store sales and the decrease in total company sales is the shift in the company's fiscal calendar for the 53rd week in fiscal 2017 and the timing of the Call of Duty launch.
|
VFC | Hot Stocks07:57 EDT VF Corp. expects Vans revenue to be up 23% in 2019 - Sees 2019 adjusted gross margin "at least" 51%. Sees adjusted operating margin approx. 13.6%. Says revenue for Outdoor is expected to increase 8% versus the previous expectation of 7% to 8% increase. Says revenue for Active is expected to increase 16% versus the previous expectation of a 14% to 15%. Says revenue for Work is expected to increase 39%. Says revenue for Jeans is now expected to decline 3% versus previous view of down 1% to 2%. Says expects 2019 revenue growth for Vans to be 23% versus previous view of 18%-19%. Expects North Face revenue up 8% compared to previous view of up 7% to 8%. Expects Timberland revenue to be flat compared to previous view of 2%-4%. Says expects 2019 revenue for Wrangler flat compared to previous view of up 1%. Expects Lee revenue down 5% compared to previous view of down 3%-4%. Says U.S. revenue is expected to be up 13%. Says Americas non-U.S. revenue is expected to be up 13%. Says EMEA revenue is expected to be up 7%. Says APAC revenue is expected to be up 14%. Says wholesale revenue is expected to be up 11% versus previous view of 9%-10%. Says Direct-to-consumer revenue is expected to increase 13% versus the previous expectation of 12% to 14%. Says Digital revenue is still expected to increase more than 30%. Comments taken from slides to be presented on Q3 earnings conference call.
|
TYME | Hot Stocks07:55 EDT Tyme Technologies trading halted, news pending
|
KMPH | Hot Stocks07:37 EDT KemPharm to present data from four posters at APSARD - KemPharm announced that research assessing the oral and intranasal human abuse potential, or HAP, of serdexmethylphenidate, or SDX, KemPharm's prodrug of d-methylphenidate, or d-MPH, as well as new pharmacokinetic, or PK, data for KP415, will be presented in four posters and one oral "data blitz session" at the annual meeting of the American Professional Society for ADHD and Related Disorders, or APSARD. SDX is the major active pharmaceutical ingredient in KP415 and KP484, KemPharm's co-lead clinical development product candidates intended for the treatment of attention-deficit/hyperactivity disorder, or ADHD, as well as KP879, a newly identified product candidate being developed for the treatment of Stimulant Use Disorder, or SUD. The first poster was a single-dose, single-period study of orally administered KP415 capsules in children 6-12 years of age and adolescents 13-17 years of age. Consistent with prior studies of methylphenidate products, the study found that systemic dose-normalized exposure to d-MPH following oral administration of KP415 was higher in younger children, which appears to be related to lower d-MPH clearance in subjects with lower body weights. The second poster was a Phase 1, open-label, randomized, single-dose, 3-treatment, 3-period crossover study evaluating the PK's of three clinical doses of KP415 in healthy adults. KP415 produced dose-proportional increases in the rate and extent of d-MPH exposure across a relatively wide range of doses, and steady-state plasma concentrations were achieved prior to the third dose. The third poster also featured as one of eight posters selected to participate in an oral "data blitz session." This was a Phase 1, randomized crossover, double-blind, single-dose, active- and placebo-controlled study that compared the HAP and PK's of intranasally administered, or IN, SDX and IN d-MPH HCl in recreational stimulant users with a history of intranasal stimulant use. IN SDX produced lower exposure to d-MPH relative to IN d-MPH HCl, and correspondingly, produced pharmacodynamic effects that were significantly lower than IN d-MPH HCI on multiple abuse-related endpoints, including the primary endpoint of maximal drug liking. Finally, the fourth poster was a Phase 1, randomized crossover, double-blind, single-dose, active- and placebo-controlled study of orally administered SDX in recreational stimulant users. The study found that SDX produced a gradual onset of abuse-related effects and maximal effects which were statistically lower than Focalin XR on all abuse-related endpoints and statistically lower than phentermine on a majority of abuse-related endpoints. KemPharm funded the studies which were conducted at various external clinical facilities.
|
SUN ATIS | Hot Stocks07:33 EDT Sunoco acquires fuel distribution businesses, sells ethanol facility to Attis Industries - Sunoco (SUN) completed the acquisition of the wholesale fuel distribution business from Schmitt Sales and the execution of a definitive agreement to acquire certain convenience store locations from Speedway. Sunoco will convert the acquired convenience store locations to wholesale distribution sites. Combined, these wholesale fuels businesses distribute approximately 180 million gallons of fuel annually in the Upstate New York, Ohio, Pennsylvania and West Virginia markets. Total consideration for both acquisitions is approximately $50M plus working capital adjustments. Sunoco will fund the transactions with cash on hand and amounts available under its revolving credit facility. These transactions are expected to be accretive to Sunoco with respect to distributable cash flow in the first year. Additionally, Sunoco executed a definitive asset purchase agreement with Attis Industries (ATIS) for the sale of Sunoco's ethanol plant in Fulton, New York. As part of the transaction, Sunoco will enter into a 10-year ethanol offtake agreement with Attis. Total consideration for the divestiture is $20M in cash. Sunoco expects to use the proceeds to repay indebtedness. The transaction is expected to close in Q1.
|
MOXC | Hot Stocks07:31 EDT Moxian enters strategic partnership with Sihe Media - Moxian announced announced the signing of a strategic partnership and cooperation agreement with Fujian Sihe Media Co., Ltd., a Fujian-based mobile marketing company. The two parties are both willing to build a comprehensive and in-depth partnership through sharing of resources including cross reference of clients, joint effort in data technology and platform development, and joint marketing programs for customers that are in need of technology-driven, multi-channel, multi-platform, advertising and marketing solutions.
|
CELG | Hot Stocks07:14 EDT Celgene enters strategic collaboration with Obsidian Therapeutics - Obsidian Therapeutics announced a strategic collaboration with Celgene for the discovery and development of novel, regulated cell therapies that utilize Obsidian's Destabilizing Domain, or DD, technology. Specifically, the collaboration is based on Obsidian's DD technology for the controlled expression of two immunomodulatory factors, IL12 and CD40L, that have the potential to augment the power of adoptive cell therapies but require precise control to optimize their therapeutic benefit. This multi-year collaboration provides Celgene with the exclusive option to in-license worldwide rights for cell therapy candidates that incorporate DD-regulated IL12 or CD40L for the treatment of cancer. The collaboration includes an upfront payment and equity investment by Celgene, and potential future milestone and royalty payments.
|
CELG | Hot Stocks07:13 EDT Celgene enters strategic collaboration with Kyn Therapeutics - Kyn Therapeutics announced it has entered into a global strategic collaboration with Celgene. The goal of the collaboration is to develop novel immuno-oncology therapies through uniting Kyn's immuno-oncology expertise and pipeline with Celgene's capabilities for developing and commercializing medicines in areas of high unmet medical need. The collaboration begins with an upfront payment and an equity investment by Celgene, which receives exclusive options to license Kyn's aryl hydrocarbon receptor, or AHR, antagonist program and its kynurenine-degrading enzyme program. AHR and kynurenine are associated with immunosuppression in a range of tumor types through multiple cellular metabolic mechanisms that modulate both innate and adaptive immunity. These attributes make them compelling targets for investigative therapies, in particular in patients who do not fully benefit from current treatments like checkpoint inhibitors.
|
VFC | Hot Stocks07:12 EDT VF Corp. up 8% to $79.00 after raising FY19 outlook
|
CTB | Hot Stocks07:12 EDT Cooper Tire Europe to cease light vehicle tire production in England facility - Cooper Tire & Rubber Company Europe Ltd., a subsidiary of Cooper Tire, announced it will move forward with a previously announced proposal to cease light vehicle tire production at its Melksham, England facility. The plan is geared to help Cooper Tire Europe enhance its competitiveness in the global tire industry. The collective consultation process with employee representatives at the facility, which began in October 2018, has concluded and it is expected that light vehicle tire production will be phased out over a period of approximately 10 months at the site with an estimated 300 roles eliminated. Cooper Tire Europe will obtain light vehicle tires to meet customer needs from other sites within Cooper's global production network. Employees whose roles will be eliminated will receive appropriate notice, enhanced separation pay and continued career services. Approximately 400 roles will remain in Melksham to support functions that will continue there, including motorsports and motorcycle tire production, a materials business, Cooper Tire Europe headquarters and sales and marketing, and the Europe Technical Center.
|
SLB | Hot Stocks07:12 EDT Schlumberger says oil price volatility creates uncertainty around E&P spending - Schlumberger Chairman and CEO Paal Kibsgaard commented, "Looking forward to 2019, we expect a more positive supply- and demand-balance sentiment to lead to a gradual recovery in the price of oil over the course of the year, as the OPEC and Russia cuts take full effect; the effect of lower activity in North America land in the second half of 2018 impacts production growth; the dispensations from the Iran export sanctions expire and are not renewed; and as the US and China continue to work toward a solution to their ongoing trade dispute. In the meantime, the recent oil price volatility has introduced more uncertainty around the E&P spending outlook for 2019, with customers generally taking a more conservative approach at the start of the year. This will once again push out in time the broad-based recovery in E&P spending that we expected only three months ago. However, based on our recent discussions with customers, we are seeing clear signs that E&P investments are starting to normalize and reflect a more sustainable financial stewardship of the global resource base. For the North America land E&P operators, this means that future investments will likely be much closer to the level that can be covered by free cash flow. Conversely, in the international markets apart from the Middle East and Russia, after four years of underinvestment and a focus on maximizing cash flow, the NOCs and independents are starting to see the need to invest in their resource base simply to maintain production at current levels. For Schlumberger, this means that even with the current oil prices, we expect solid, single-digit growth in the international markets while in North America land, the increased cost of capital and focus on aligning investments closer to free cash flow has introduced more uncertainty to the outlook for both drilling and production activity. In this environment, we have built significant flexibility into our operating plan for 2019, which gives us the means and confidence to address any investment and activity scenario. Furthermore, the foundation for our 2019 plans is a clear commitment to generate sufficient cash flow to cover all our business needs, without increasing net debt. After a very strong free cash flow performance in the second half of 2018, we are confident in our ability to further improve our liquidity position in 2019, through our focus on top-line growth, incremental margins, capital discipline, and careful management of working capital."
|
VFC | Hot Stocks07:04 EDT VF Corp. reports Q3 gross margin up 40 bps to 51.9% - Gross margin increased 40 basis points to 51.9%, driven by a mix-shift toward higher margin businesses. On an adjusted basis, gross margin increased 60 basis points to 52.2%.
|
AZN IRWD | Hot Stocks07:03 EDT AstraZeneca reports Linzess approved in China for IBS-C - AstraZeneca (AZN) announced that its partner Ironwood Pharmaceuticals (IRWD) has received marketing authorization from the National Medical Products Administration for Linzess in China for the treatment of adult patients with irritable bowel syndrome with constipation, or IBS-C. Launch of Linzess in China is expected in the second half of 2019. Under the terms of the collaboration, AstraZeneca will record Product Sales and share the net profits and losses associated with Linzess in China, with AstraZeneca carrying 55% of each until a certain specified milestone is achieved, moving to a 50/50 split thereafter. Ironwood will also be eligible for up to $125M in additional commercial milestone payments contingent on the achievement of certain sales targets.
|
VFC | Hot Stocks07:03 EDT VF Corp. CEO says Q3 results 'fueled by strong growth in our largest brands' - "VF's third quarter results were fueled by strong growth in our largest brands and balanced growth across the core dimensions of our portfolio," said Steve Rendle, Chairman, President and CEO. "Based on the strength of our third quarter performance and the growth trajectory we see for the remainder of fiscal 2019, we are again increasing our full year outlook, including an additional $45 million of growth-focused investments aimed at accelerating growth and value creation into fiscal year 2020. We remain sharply focused on executing our integrated growth strategy and transforming VF into a purpose-led, performance-driven enterprise committed to delivering superior returns to shareholders."
|
AVRO | Hot Stocks07:03 EDT Avrobio announces FDA acceptance of AVR-RD-04 IND application - Avrobio announced that its investigational gene therapy candidate for cystinosis, AVR-RD-04, is cleared to begin a Phase 1/2 clinical trial, following acceptance of the investigational new drug, or IND, application by the FDA. The Phase 1/2 clinical trial is a planned investigator-sponsored trial to be conducted by the University of California, San Diego. AVR-RD-04 is designed as one-time gene therapy and is being investigated for the treatment of cystinosis by inserting the functional gene for human cystinosin, or CTNS, and is designed to maximize the likelihood of sustained CTNS production in patients to correct for the single-gene defect in the CTNS gene that causes cystinosis.
|
OII | Hot Stocks07:02 EDT Oceaneering awarded three subsea umbilical contracts for over $80M - Oceaneering secured three subsea umbilical contracts valued in excess of $80M in total. The contracts with major international operators are to supply developments in the Mediterranean Sea, the North Sea and the South China Sea. Manufacture of the umbilicals is expected to commence in Q1 with deliveries scheduled during 1H20. Approximately 70% of the combined award value will be reflected in the company's December 31, 2018 backlog.
|
WHR | Hot Stocks07:01 EDT Whirlpool names Gilles Morel as new President of EMEA region - Whirlpool announced Gilles Morel as President of the Europe, Middle East and Africa Region and Executive Vice President. In this role, he will report directly to Chairman and CEO Marc Bitzer. Morel brings more than 25 years' experience in the consumer goods industry, leading sales, operations, marketing, manufacturing, research and development, and procurement, including several regional leadership roles. His role with Whirlpool is effective April 1.
|
VFC | Hot Stocks06:59 EDT VF Corp. sees FY19 cash flow from operations approximately $1.8B - Other full year assumptions include an effective tax rate of about 16% and capital expenditures of approximately $275M.
|
VFC | Hot Stocks06:58 EDT VF Corp. sees FY19 adjusted gross margin at least 51% - Adjusted operating margin is expected to increase 90 basis points to 13.6%.
|
VFC | Hot Stocks06:55 EDT VF Corp. raises FY19 outlook
|
FANH | Hot Stocks06:54 EDT Fanhua comments on unusual trading activities - Fanhua issued a statement in response to the unusual trading activities that occurred on January 17: "The unusual stock trading volatility was caused by a report which made groundless accusations and deliberate out-of-context misinterpretation, in an attempt to profit from the decline of the stock price of the company through short selling attack. The company strongly condemns such a malicious act. The company has consistently and strictly complied with SEC rules and regulations including the requirements for fair, prompt and full disclosure, for the past 11 years as a publicly listed company on Nasdaq. The company has also strictly abided by applicable laws and regulations in its business operations. The company's cashflow and profits have been closely aligned. The management remain committed to fulfilling their fiduciary duties to shareholders with continued profit growth and dividend increase. In line with its commitment to protect investors' interests, the company is carefully reviewing the report and will make an announcement clarifying and refuting the allegations raised in the report in an open and transparent manner, before market opens on January 22, 2019 (...)."
|
LLY | Hot Stocks06:51 EDT Eli Lilly announces ANNOUNCE study of Lartruvo did not meet primary endpoints - Eli Lilly reported that the results of ANNOUNCE, the Phase 3 study of Lartruvo in combination with doxorubicin in patients with advanced or metastatic soft tissue sarcoma, or STS, did not confirm the clinical benefit of Lartruvo in combination with doxorubicin as compared to doxorubicin, a standard of care treatment. Specifically, the study did not meet the primary endpoints of overall survival, or OS, in the full study population or in the leiomyosarcoma, or LMS sub-population; there was no difference in survival between the study arms for either population. Lartruvo was well tolerated; there were no new safety signals identified and the safety profile was comparable between treatment arms. Lilly plans to present the ANNOUNCE data at an upcoming medical conference and will publish the results in a medical journal. Lartruvo in combination with doxorubicin previously showed an OS benefit in STS in a 133-patient, U.S.-only, randomized Phase 2 trial, which led to accelerated approval by the FDA and conditional marketing authorization by the European Medicines Agency. Continued approval is contingent upon verification of clinical benefit in a confirmatory trial. As ANNOUNCE did not confirm clinical benefit, Lilly is working with global regulators to determine the appropriate next steps for Lartruvo. While these discussions are ongoing, patients who are currently receiving Lartruvo may, in consultation with their physician, continue their course of therapy if they are receiving clinical benefit. For patients who have not previously received Lartruvo, the results of the Phase 3 trial do not support initiating treatment with Lartruvo in patients with STS, outside of participation in a clinical trial. At this time, Lilly is suspending promotion of Lartruvo. Lartruvois also being studied in an ongoing global, randomized, double-blind, placebo-controlled Phase 2 trial in advanced STS in combination with gemcitabine and docetaxel. Lilly expects to incur a charge in Q1 related to Lartruvo. The exact amount of the charge has not yet been determined, but is estimated to be in the range of $70M-$90M, or approximately 10c per share. In addition, the company expects this to have an impact of approximately 17c per share on Lilly's FY19 earnings per share guidance. Lilly will provide a full update to its 2019 financial guidance, including the impact of the potential Loxo Oncology acquisition, when it announces Q4 earnings. This announcement does not change Lilly's 2020 minimum financial goals.
|
TIF | Hot Stocks06:47 EDT Tiffany says expects to report record levels of net sales, net earnings in FY18 - Alessandro Bogliolo, CEO, said, "With continued strong sales growth in mainland China (by a double-digit percentage), solid results in Japan and healthy growth in global ecommerce sales, overall holiday sales results came in short of our expectations which had called for modest year-over-year growth. We attribute the difference partly to lower sales to foreign (primarily Chinese) tourists globally, and to softening demand attributed to local customers in the Americas and Europe, which we believe may have been influenced more than expected by external events, uncertainties and market volatilities." Bogliolo added, "As I reflect on 2018, we accomplished what we set out to achieve. By increasing the levels of strategic investment spending in certain areas, we recovered lost ground from several years of soft sales trends and we expect to report record levels of net sales and net earnings in fiscal 2018. Now the focus is to grow to new heights. To this purpose, we will continue to pursue the six key strategic priorities we introduced earlier in 2018 (Amplifying an evolved brand message; Renewing our product offerings and enhancing in-store presentations; Delivering an exciting omnichannel customer experience; Strengthening our competitive position and leading in key markets; Cultivating a more efficient operating model; and Inspiring an aligned and agile organization to win) which will require our on-going effort and commitment for years to come. We are excited about making further meaningful progress on this journey in 2019, with plans for new product launches, an evolved marketing message, store expansions and website enhancements. We acknowledge that external pressures, difficult year-over-year sales comparisons and annualized internal spending are expected to have some negative effects on fiscal 2019 results, mostly in the first half of the year, but we believe that Tiffany is on a solid path for improved sales, margins, earnings and cash flow generation over the long-term."
|
TIF | Hot Stocks06:46 EDT Tiffany reports worldwide 2018 holiday period sales down 1% to $1.04B - Tiffany reported its sales results for the two months ended December 31, 2018. Worldwide net sales declined 1% to $1.04B and comparable sales declined 2%. However, on a constant-exchange-rate basis that excludes the effect of translating foreign-currency-denominated sales into U.S. dollars, both net sales and comparable sales were equal to the prior year.
|
TIF | Hot Stocks06:45 EDT Tiffany says expects to report record levels of net sales, net earnings in FY18 - Alessandro Bogliolo, CEO, said, "With continued strong sales growth in mainland China (by a double-digit percentage), solid results in Japan and healthy growth in global ecommerce sales, overall holiday sales results came in short of our expectations which had called for modest year-over-year growth. We attribute the difference partly to lower sales to foreign (primarily Chinese) tourists globally, and to softening demand attributed to local customers in the Americas and Europe, which we believe may have been influenced more than expected by external events, uncertainties and market volatilities." Bogliolo added, "As I reflect on 2018, we accomplished what we set out to achieve. By increasing the levels of strategic investment spending in certain areas, we recovered lost ground from several years of soft sales trends and we expect to report record levels of net sales and net earnings in fiscal 2018 (see "Fiscal 2018 Outlook" below). Now the focus is to grow to new heights. To this purpose, we will continue to pursue the six key strategic priorities we introduced earlier in 2018 (Amplifying an evolved brand message; Renewing our product offerings and enhancing in-store presentations; Delivering an exciting omnichannel customer experience; Strengthening our competitive position and leading in key markets; Cultivating a more efficient operating model; and Inspiring an aligned and agile organization to win) which will require our on-going effort and commitment for years to come. We are excited about making further meaningful progress on this journey in 2019, with plans for new product launches, an evolved marketing message, store expansions and website enhancements. We acknowledge that external pressures, difficult year-over-year sales comparisons and annualized internal spending are expected to have some negative effects on fiscal 2019 results, mostly in the first half of the year, but we believe that Tiffany is on a solid path for improved sales, margins, earnings and cash flow generation over the long-term."
|
CFG | Hot Stocks06:36 EDT Citizens Financial reports Q4 net interest margin 3.22% - Net interest income of $1.2B increased $24M, reflecting 2% average loan growth and a three basis point improvement in net interest margin to 3.22% from third quarter levels.
|
CFG | Hot Stocks06:35 EDT Citizens Financial CEO says increasing ROTCE target to 14%-16% - "We are pleased to end the year with another quarter of strong results for Citizens, continuing our track record of consistent execution and delivering against our goals," said Chairman and CEO Bruce Van Saun. "We are executing well and head into 2019 with good momentum as evidenced by our continued strong operating leverage, balance sheet growth, expanding customer base and broadening of our capabilities, including our recent acquisition of Clarfeld Financial Advisors." Van Saun continued, "We are pleased to have already achieved the lower end of our medium-term ROTCE target and are now increasing the range to 14 to 16 percent. Our strong performance has allowed us to raise our dividend today by a further 19%, as we continue to deliver strong value for all our stakeholders."
|
CFG | Hot Stocks06:33 EDT Citizens Financial board declares a 19% increase in quarterly stock dividend
|
CVS WMT | Hot Stocks06:32 EDT CVS, Walmart announce new PBM pharmacy network agreement, terms not disclosed - CVS Health (CVS) and Walmart (WMT) announced the companies have reached a multi-year agreement on terms under which Walmart will continue participating in the CVS Caremark pharmacy benefit management, or PBM, commercial and Managed Medicaid retail pharmacy networks. The companies are not disclosing the financial terms of the new contract. With the continuing participation of Walmart, the CVS Caremark national pharmacy network will have nearly 68,000 participating pharmacies for members to choose from, including independently-owned, community-based pharmacies, other local pharmacies in grocery stores and mass merchants, as well as regional and national chains. Walmart and CVS Health already have an existing agreement in place for Walmart's participation in the CVS Caremark Medicare Part D pharmacy network. In addition, Walmart's Sam's Club division has an existing agreement to participate in the CVS Caremark pharmacy networks.
|
CFG | Hot Stocks06:32 EDT Citizens Financial reports Q4 ROTCE 13.8%, underlying ROTCE of 14.1%
|
CVS WMT | Hot Stocks06:31 EDT CVS Health, Walmart announce new PBM pharmacy network agreement
|
MSFT | Hot Stocks06:24 EDT Microsoft to spend $500M to build affordable housing in Seattle - Microsoft announced it will spend $500M on building affordable housing in Seattle. President Brad Smith and CFO Amy Hood said in a blog post: "The Puget Sound area's growth has also created new challenges. In recent years, our region hasn't built enough housing for the people who live here. Since 2011, jobs in the region have grown 21 percent, while growth in housing construction has lagged at 13 percent. This gap in available housing has caused housing prices to surge 96 percent in the past eight years, making the Greater Seattle area the sixth most expensive region in the United States... We are committing $500 million as a company to advance affordable housing solutions. We'll put this money to work with loans and grants to accelerate the construction of more affordable housing across the region. We will invest: $225 million at lower than market rate returns to inject capital to subsidize the preservation and construction of middle-income housing. $250 million at market rate returns to support low-income housing across the entire King County region. $25 million in philanthropic grants to address homelessness in the greater Seattle region."
|
CRVL | Hot Stocks06:16 EDT CorVel promotes Michael Combs to CEO, effective January 18 - CorVel announced that its Board of Directors has promoted the company's President, Michael Combs, to also serve as its CEO, effective January 18. Combs was previously promoted to President in April 2017 and served as Chief Information Officer from April 2015 to April 2017. Combs has been with the company for more than 27 years, joining the company as a software engineer in October 1991. His prior positions at the company include Vice President of Bill Review Development and Deputy Chief Information Officer.
|
TSLA | Hot Stocks06:14 EDT Tesla sinks 8%, or $28.28, to $319.03 after announcing 7% workforce reduction
|
GLOB | Hot Stocks06:14 EDT Globant to acquire Avanxo - Globant announced it has entered into a binding agreement to acquire Avanxo, a cloud transformation company with presence in the United States, Brazil, Mexico, Colombia, Peru and Argentina. Subject to completion of certain requirements set forth in the purchase agreement, the transaction is expected to close in February. With this acquisition, Globant continues to focus its capabilities in creating digital experiences for large organizations worldwide, expanding its broad expertise in corporate process optimization and cloud technologies. Avanxo pioneered the cloud system integration market in Latin America.
|
TSLA | Hot Stocks06:08 EDT Tesla says to make job cuts while increasing Model 3 production rate
|
TSLA | Hot Stocks06:07 EDT Tesla sees GAAP profit in Q4, 'but less than Q3' - Elon Musk said in an email to Tesla employees, "This quarter, as with Q3, shipment of higher priced Model 3 variants (this time to Europe and Asia) will hopefully allow us, with great difficulty, effort and some luck, to target a tiny profit."
|
RF | Hot Stocks06:06 EDT Regions Financial reports Q4 net interest margin 3.55% up 5 bps sequentially
|
TSLA | Hot Stocks06:05 EDT Tesla: Road ahead is 'very difficult'
|
TSLA | Hot Stocks06:04 EDT Tesla sees GAAP profit in Q4, 'but less than Q4' - Elon Musk said in an email to Tesla employees, "This quarter, as with Q3, shipment of higher priced Model 3 variants (this time to Europe and Asia) will hopefully allow us, with great difficulty, effort and some luck, to target a tiny profit."
|
TSLA | Hot Stocks06:03 EDT Tesla: Products still too expensive for most people
|
RF | Hot Stocks06:03 EDT Regions Financial CEO says 'we have positive momentum heading into 2019' - "This year we delivered high-quality growth in loans, non-interest income and households while also building a more efficient and effective company," said John Turner, President and CEO. "Our team finished the year strong achieving record full-year earnings driven by solid revenue generation, expense management and a focus on continuous improvement. Through our Simplify and Grow initiative, we made structural changes to create a more nimble organization while making strategic investments in talent and technology to better serve our customers. We have positive momentum heading into 2019 and are well-positioned to generate consistent and sustainable long-term performance across economic cycles."
|
TSLA | Hot Stocks06:03 EDT Tesla to reduce full-time employee headcount by approximately 7% - In a memo to employees by CEO Elon Musk posted on Tesla's website, Musk said: "In Q3 last year, we were able to make a 4% profit. While small by most standards, I would still consider this our first meaningful profit in the 15 years since we created Tesla. However, that was in part the result of preferentially selling higher priced Model 3 variants in North America. In Q4, preliminary, unaudited results indicate that we again made a GAAP profit, but less than Q3. This quarter, as with Q3, shipment of higher priced Model 3 variants (this time to Europe and Asia) will hopefully allow us, with great difficulty, effort and some luck, to target a tiny profit. However, starting around May, we will need to deliver at least the mid-range Model 3 variant in all markets, as we need to reach more customers who can afford our vehicles. Moreover, we need to continue making progress towards lower priced variants of Model 3. Right now, our most affordable offering is the mid-range (264 mile) Model 3 with premium sound and interior at $44k. The need for a lower priced variants of Model 3 becomes even greater on July 1, when the US tax credit again drops in half, making our car $1,875 more expensive, and again at the end of the year when it goes away entirely... As a result of the above, we unfortunately have no choice but to reduce full-time employee headcount by approximately 7% (we grew by 30% last year, which is more than we can support) and retain only the most critical temps and contractors. Tesla will need to make these cuts while increasing the Model 3 production rate and making many manufacturing engineering improvements in the coming months. Higher volume and manufacturing design improvements are crucial for Tesla to achieve the economies of scale required to manufacture the standard range (220 mile), standard interior Model 3 at $35k and still be a viable company. There isn't any other way." Reference Link
|
RF | Hot Stocks06:02 EDT Regions Financial reports Q4 net interest margin 3.55% up 5 bps y/y
|
FLIR | Hot Stocks06:02 EDT Flir Systems awarded $89M contract from French Armed Forces - Flir Systems has been awarded a contract from the French Defense Procurement Agency in support of the French Operational Pocket Drone program. The contract has a ceiling value of $89M to provide the FLIR Black Hornet 3 nano-unmanned aerial vehicle and Personal Reconnaissance System to support French Armed Forces operations. The contract will be managed and executed by Flir in Hvalstad, Norway.
|
TSLA | Hot Stocks06:01 EDT Tesla to reduce full-time employee headcount by approximately 7%
|
MGM | Hot Stocks05:56 EDT MGM Resorts names Corvex's Keith Meister to board - MGM Resorts International announced that Keith A. Meister has been appointed to the company's Board of Directors, effective tomorrow, January 18, 2019. With his appointment, the company's Board has been expanded from 12 to 13 directors. Mr. Meister is Managing Partner and Chief Investment Officer of Corvex Management LP, which beneficially owns approximately 3% of MGM's outstanding shares. Mr. Meister has extensive boardroom experience and previously served as a director on the boards of Yum! Brands, Inc., The Williams Companies, The ADT Corporation, Ralcorp Holdings, Motorola, Inc./Motorola Mobility, Inc. and American Casino & Entertainment Properties, among others.
|
JRJC | Hot Stocks05:48 EDT China Finance Online forms strategic partnership with Founder CIFCO Futures - China Finance Online announced it has signed a strategic partnership agreement with Founder CIFCO Futures, a futures brokerage firm in China. Pursuant to the partnership agreement, both parties will collaborate and explore in the development of a more advanced trading system, smart news alerts of the market, a cloud-based research platform and industry forums.
|
CRM | Hot Stocks05:47 EDT Salesforce announces Salesforce Tower Dublin, to add 1,500 new jobs in Ireland - Salesforce announced Salesforce Tower Dublin, significantly expanding the company's regional headquarters in Ireland. As part of the expansion, Salesforce plans to add 1,500 new local jobs over the next five years. Salesforce.org, the philanthropic arm of Salesforce, also announced a $1 million grant to Educate Together, supporting the opening and running of schools in Ireland. Today's announcements were made with the Irish Prime Minister, An Taoiseach Leo Varadkar TD at an event in the Convention Centre Dublin where nearly 1,000 Salesforce employees were present to hear details of the new plans. Salesforce Tower Dublin will be an urban campus of four interconnected buildings located on North Wall Quay within Dublin's vibrant Silicon Docks, overlooking the River Liffey. Salesforce employees are due to start moving into the 430,000 Sq ft campus in mid-2021. Salesforce Tower Dublin is being developed by Ronan Group Real Estate and Colony Capital.
|
CETV | Hot Stocks05:26 EDT Central European Media announces decision to retain Slovenian operations - Central European Media announced it has terminated the agreement, previously announced on July 10, 2017, to sell its operations in Slovenia, and will instead retain full ownership of the leading television network group in the country. CME will present the results of the Slovenian business as continuing operations when announcing its full year 2018 results. On this basis, for the last twelve months ended September 30, 2018: OIBDA for the Slovenian operations was $20.8M, CME's operating income was $162.3 and OIBDA was $208.4M. Run-rate annual debt service obligations for CME were $29M.
|
YI | Hot Stocks05:12 EDT 111, Inc. CFO Weihao Xu to depart March 7 - 111, Inc. announced that Weihao Xu has resigned as CFO and director for personal reasons. The company has begun a process to appoint a successor to Xu and a further announcement will be made in due course. Xu will stay until March 7, 2019 to help with the transition.
|